Researchers have at last identified the precise cause of the unusual blood clot condition associated with specific COVID-19 vaccines and adenovirus infections. In this video, we delve into the revolutionary finding that shows how a minor mutation in an immune cell can cause antibodies to target a regular blood protein, leading to VITT. Discover the mechanism behind this rare immune error, its infrequency, and how this significant advancement may aid scientists in creating even safer vaccines in the future. A considerable medical puzzle unraveled by a single molecular alteration.
